SHA:688193 Revenue

In the year 2025, Shanghai Rendu Biotechnology had annual revenue of 161.94M CNY, down -8.69%. Shanghai Rendu Biotechnology had revenue of 42.79M in the quarter ending December 31, 2025, a decrease of -8.39%.

Revenue

161.94M

Revenue Growth

-8.69%

P/S Ratio

14.77

Revenue / Employee

483.41K

Employees

290

Market Cap

2.39B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	161.94M	-15.41M	-8.69%
Dec 31, 2024	177.35M	12.94M	7.87%
Dec 31, 2023	164.41M	-139.44M	-45.89%
Dec 31, 2022	303.85M	11.54M	3.95%
Dec 31, 2021	292.31M	42.40M	16.97%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chemclin Diagnostics	353.32M
Berry Genomics Co.,Ltd	941.16M
Medicalsystem Biotechnology	1.47B
Shanghai Labway Clinical Laboratory	1.52B
Guangdong Hybribio Biotech	691.16M
SMO ClinPlus CO.,LTD.	819.09M
Thalys Medical Technology Group	1.25B
Cowealth Medical China	656.38M

Revenue Rankings